Genetic variations in carcinogen metabolizing genes associated with oral cancer in Pakistani population

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 2, 2011, Pages 491-495

  Masood, Nosheen ^a   Kayani, Mahmood Akhtar ^a   Malik, Fraz Arshad ^a   Mahjabeen, Ishrat ^a   Baig, Ruqia Mehmood ^a   Faryal, Rani ^a  

^a COMSATS Institute of Information and Technology ^*  (Pakistan)

Author keywords

CYP1A1; GSTM1; GSTP1; GSTT1; Oral cancer; Pakistan; Polymorphisms

Indexed keywords

CYTOCHROME P450 1A1; DNA; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; GSTP1 PROTEIN, HUMAN;

ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; MOUTH TUMOR; MUTATION; PAKISTAN; POLYMERASE CHAIN REACTION; PROGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; DNA, NEOPLASM; FEMALE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MUTATION; PAKISTAN; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS;

EID: 79958858781     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Ali OF, Akande O, Antoun G, et al (1997). Molecular cloning, characterization, and expression in Escherichia coli, of full length cDNA of three human glutathione S-transferase P1 gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem, 272, 10004-12.
2. Amalio T, Paul I, Francine M, et al (1993). Direct, automated detection of rifampin-resistant mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob Agents Chemother, 37, 2054-8.
3. Bartsch H, Nair U, Risch A, et al (2000). Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev, 9, 3-28.
4. Baumgartner-Parzer S, Schulze E, Waldhäusl W, et al (2001). Mutational spectrum of the steroid 21-hydroxylase gene in Austria, identification of a novel missense mutation. J Clin Endocrinol Metab, 86, 4771-5.
5. Buch SC, Notani PN, Bhisey RA (2002). Polymorphisms at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis, 23, 803-7.
6. Cascorbi I, Brockmoller J, Roots I (1996). A C4887A polymorphisms in exon 7 of human CYP1A1, Population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res, 56, 4965-9.
7. Cheng L, Sturgis E, Eicher S (1999). Glutathione S-transferase polymorphisms and risk of squamous cell carcinoma of the head and neck. Int J Cancer, 84, 220-4.
8. Chevalier D, Allorge D, Lo-Guidice JM, et al (2001). Detection of known and two novel (M331I and R464S) missense mutations in the human CYP1A1 gene in a French Caucasian population. Hum Mutat, 17, 355.
9. Cho CG, Lee SK, Nam SY (2006). Association of GSTP1 and NQO1 polymorphism and head and neck squamous cell carcinoma risk. J Korean Med Sci, 21, 1075-9.
10. Cocco R, Stenberg G, Dragani B, et al (2001). The folding and stability of human alpha class glutathione transferase A1-1 depend on distinct roles of a conserved N-capping box and hydrophobic staple motif. J Biol Chem, 276, 32177-83.
11. Crofts F, Cosmo GN, Taioli E, et al (1993). A novel CYP1A1 gene polymorphism in African- Americans. Carcinogenesis, 14, 1729-31.
12. Devasena A, Pranay MC, Sadhana K, et al (2007). Suseptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians, tobacco exposure as a risk modulator. Carcinogenesis, 28, 1455-62.
13. Dragani B, Stenberg G, Melino S, et al (1997). The conserved N-capping box in the hydrophobic core of glutathione S-transferase P1-1 is essential for refolding. Identification of a buried and conserved hydrogen bond important for protein stability. J Biol Chem, 272, 25518-23.
14. Duk WP, Bohan J, Dongdeuk J, et al (2004). Genetic polymorphisms of CYP1A1 in a Korean population. Arch of toxic, 78, 306-8.
15. Egan KM, Cai Q, Shu XO, et al (2004). Genetic polymorphisms in GSTM1, GSTP1 and GSTT1 and the risk for breast cancer, results from Shanghai breast cancer study and meta analysis. Cancer Epidemiol Biomarkers Prev, 13, 197-204.
16. Garte S, Gaspari L, Alexandrie AK, et al (2001). Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev, 10, 1239-48.
17. Hayashi SI, Watanabe J, Nakachi K, et al (1991). Genetic linkage of lung cancer associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P-450 gene. J Biochem, 110, 407-11.
18. Hecht SS, Carmella SG, Murphy SE, et al (1993). Carcinogen biomarkers related to smoking and upper aerodigestive tract cancer. J Cell Biochem Suppl, 17, 27-35.
19. Joanne EC, Stephen RW, Lyn RG (2000). Polymorphisms of glutathione S transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility. Cancer Lett, 153, 113-20.
20. Jun T, Ming Y, Xin N, et al (2010). Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population. Cancer Genet Cytogenet, 196, 76-82.
21. Kawajiri K, Nakachi K, Imai K, et al (1990). Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P-450 1A1 gene. FEBS Lett, 263, 131-3.
22. Kihara M, Kubota A, Furukawa M, et al (1997). GSTM1 gene polymorphism as a possible marker for susceptibility to head and neck cancers among Japanese smokers. Cancer Lett, 112, 257-62.
23. Kim WJ, Lee HL, Lee SC (2000). Polymorphisms of Nacetyltransferase2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis. J Urol, 164, 209-13.
24. Landi S (2000). Mammalian class theta GST and differential susceptibility to carcinogens, a review. Mutat Res, 463, 247-83.
25. Lee EJ, Wong JY, Yeoh PN, et al (1995). Glutathione S transferase theta (GSTT1) genetic polymorphism among Chinese, Malays and Indians in Singapore. Pharmacogenetics, 5, 332-4.
26. Mishra DK, Kumar A, Srivastava DS, et al (2004). Allelic variation of GSTT1, GSTM1 and GSTP1 gene in north Indian population. Asia Pac J Cancer Prev, 5, 362-5.
27. Moyer AM, Oreste ES, Tse YW, et al (2008). Glutathione S transferase P1, gene sequence variation and functional genomic studies. Cancer Res, 68, 4791.
28. Naoe T, Takeyama K, Yokozawa T, et al (2000). Analysis of genetic polymorphism in NQO1, GSTM1, GSTT1, and CYP3 A4 in 469 Japanese patient with therapy related leukemia myeloid plastic syndrome and denovo acute myeloid leukemia. Clin Cancer Res, 6, 4091-5.
29. Naveen AT, Adithan C, Padmaja N, et al (2004). Glutathione S transferase M1 and T1 null genotype distribution in south Indians. Eur J Clin Pharmacol, 60, 403-6.
30. Nazar VS, Vaughan T, Burt R, et al (1999). Glutathione S transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol Bio Prev, 8, 547-51.
31. Palli D, Vineis P, Russo A (2000). Diet, metabolic polymorphisms and DNA adducts, the EPIC-Italy cross-sectional study. Int J Cancer, 87, 444-51.
32. Park SK, Yoo KY, Lee SJ (2000). Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics, 10, 301-9.
33. Patricia S, Melissa M, Robert HG, et al (2009). Sputum PCRsingle-strand conformational polymorphism test for sameday detection of pyrazinamide resistance in tuberculosis patients. J Clin Microbiol, 47, 2937-43.
34. Patrick KH, Steven SC, Chad AG, et al (2009). Molecular techniques and genetic alterations in head and neck cancer. Oral Oncol, 45, 335-9.
35. Pemble S, Schroeder K, Spencer S (1994). Human glutathione S-transferase theta (GSTT1), cDNA cloning and the characterization of a genetic polymorphism. Biochem J, 300, 271-6.
36. Peters EH, McClean MD, Marsit CJ, et al (2006). Glutathione S tranferase polymorphism and the synergy of alcohol and tobacco in oral, pharyngeal and laryngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 15, 2196-202.
37. Rebbeck T, Walker A, Jaffe J (1999). Glutathione S-transferase mu (GSTM1) abd -theta (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiol Biomarkers Prev, 8, 283-7.
38. Rebbeck TR (1997). Molecular epidemiology of human gluthation S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 6, 733-43.
39. Rossjohn J, McKinstry WJ, Oakley AJ, et al (2000). Structures of thermolabile mutants of human glutathione transferase P1. J Mol Biol, 302, 295-302.
40. Saito S, Iida A, Sekine A, et al (2002). 906 variations among 27 genes encoding cytochrome P450 (CYP) enzymes and aldehyde dehydrogenases (ALDHs) in the Japanese population. J Hum Genet, 47, 419-44.
41. Schneider J, Bernges U, Philipp M, et al (2004). GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett, 208, 65-74.
42. Setiawan VW, Zhang ZF, Yu ZU, et al (2000). GSTT1 and GSTM1 null genotypes and risk of gastric cancer, a casecontrol study in a Chinese population. Cancer Epidemiol Biomarkers Prev, 9, 73-80.
43. Singh S, Kumar V, Thakura S, et al (2009). Genetic polymorphism of glutathione S-transferase M1 and T1 in Delhi population of Northern India. Environ Toxicol Phar, 28, 25-9.
44. Smart J, Daly AK (2000). Variation in induced CYP1A1 levels, relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics, 10, 11-24.
45. Spurr NK, Gough AC, Stevenson K, et al (1987). Msp-1 polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res, 15, 5901.
46. Stacy AG, Andrew FO (2000). GSTT1 and GSTM1, and the risk of squamous cell carcinoma of the head and neck, a mini huge review. Am J Epidemiol, 154, 95-105.
47. Toefil L, Oana CT, Horea AA, et al (2007). Head and neck cancer, epidemiology and histological aspects- Part 1, a decades results 1993-2003. J Craniomaxillofac Surg, 35, 120-5.
48. Toru H, Masaharu Y, Shinji T, et al (2008). Genetic polymorphisms and head and neck cancer risk. Int J Oncol, 32, 945-73.
49. Trizna Z, Clayman G, Spitz M, et al (1995). Glutathione S transferase as risk factor for head and neck cancers. Am J Surg, 170, 499-501.
50. Vierhapper H, Bieglmayer C, Heinze G, et al (2004). Frequency of RET protooncogene mutations in patients with normal and with moderately elevated (50-100 pg/ml) pentagastrinstimulated serum concentrations of calcitonin. Thyroid, 14, 580-3.
51. Xiang DL, Brett C, Oliver H (2001). Loss of CYP1A1 messenger RNA expression due to nonsense- mediated decay. Mol pharm, 60, 388-93.
52. Zimniak P, Nanduri B, Pikula S, et al (1994). Naturally occurring glutathione S- transferase GSTP1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem, 224, 893-9.